203 related articles for article (PubMed ID: 20804567)
21. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
22. SET
Sinn BV; Fu C; Lau R; Litton J; Tsai TH; Murthy R; Tam A; Andreopoulou E; Gong Y; Murthy R; Gould R; Zhang Y; King TA; Viale A; Andrade V; Giri D; Salgado R; Laios I; Sotiriou C; Marginean EC; Kwiatkowski DN; Layman RM; Booser D; Hatzis C; Vicente Valero V; Fraser Symmans W
NPJ Breast Cancer; 2019; 5():16. PubMed ID: 31231679
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.
Xiu Y; Liu W; Wang T; Liu Y; Ha M
Mol Clin Oncol; 2019 May; 10(5):497-505. PubMed ID: 30967944
[TBL] [Abstract][Full Text] [Related]
24. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis.
Zhou G; Soufan O; Ewald J; Hancock REW; Basu N; Xia J
Nucleic Acids Res; 2019 Jul; 47(W1):W234-W241. PubMed ID: 30931480
[TBL] [Abstract][Full Text] [Related]
25. 5-Year Survival Rates and Prognostic Factors in Patients with Synchronus and Metachronus Breast Cancer from 2010 to 2015.
Sarveazad A; Babahajian A; Shamseddin J; Bahardoust M
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3489-3493. PubMed ID: 30583674
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy.
Hou JZ; Xi ZQ; Niu J; Li W; Wang X; Liang C; Sun H; Fang D; Xie SQ
Oncol Rep; 2019 Mar; 41(3):1971-1979. PubMed ID: 30569119
[TBL] [Abstract][Full Text] [Related]
27. PubChem 2019 update: improved access to chemical data.
Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
[TBL] [Abstract][Full Text] [Related]
28. Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines.
Komoto TT; Bernardes TM; Mesquita TB; Bortolotto LFB; Silva G; Bitencourt TA; Baek SJ; Marins M; Fachin AL
Molecules; 2018 Aug; 23(8):. PubMed ID: 30104527
[TBL] [Abstract][Full Text] [Related]
29. GSCALite: a web server for gene set cancer analysis.
Liu CJ; Hu FF; Xia MX; Han L; Zhang Q; Guo AY
Bioinformatics; 2018 Nov; 34(21):3771-3772. PubMed ID: 29790900
[TBL] [Abstract][Full Text] [Related]
30. Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer.
Liu B; Tan J; Wang X; Liu X
Neoplasma; 2018 Mar; 65(3):360-366. PubMed ID: 29788739
[TBL] [Abstract][Full Text] [Related]
31. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
32. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.
Butti R; Das S; Gunasekaran VP; Yadav AS; Kumar D; Kundu GC
Mol Cancer; 2018 Feb; 17(1):34. PubMed ID: 29455658
[TBL] [Abstract][Full Text] [Related]
33. FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring
Odogwu L; Mathieu L; Blumenthal G; Larkins E; Goldberg KB; Griffin N; Bijwaard K; Lee EY; Philip R; Jiang X; Rodriguez L; McKee AE; Keegan P; Pazdur R
Oncologist; 2018 Jun; 23(6):740-745. PubMed ID: 29438093
[TBL] [Abstract][Full Text] [Related]
34. Finding hidden treasures in old drugs: the challenges and importance of licensing generics.
Simsek M; Meijer B; van Bodegraven AA; de Boer NKH; Mulder CJJ
Drug Discov Today; 2018 Jan; 23(1):17-21. PubMed ID: 28867540
[TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer.
Miyamoto Y; Suyama K; Baba H
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368335
[TBL] [Abstract][Full Text] [Related]
36. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
37. BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.
Ghaffari K; Hashemi M; Ebrahimi E; Shirkoohi R
Iran Biomed J; 2016 Sep; 20(4):241-5. PubMed ID: 27372966
[TBL] [Abstract][Full Text] [Related]
38. Low expression of leptin and its association with breast cancer: A transcriptomic study.
Karim S; Merdad A; Schulten HJ; Jayapal M; Dallol A; Buhmeida A; Al-Thubaity F; Mirza Z; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Oncol Rep; 2016 Jul; 36(1):43-8. PubMed ID: 27177292
[TBL] [Abstract][Full Text] [Related]
39. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients.
Gruosso T; Mieulet V; Cardon M; Bourachot B; Kieffer Y; Devun F; Dubois T; Dutreix M; Vincent-Salomon A; Miller KM; Mechta-Grigoriou F
EMBO Mol Med; 2016 May; 8(5):527-49. PubMed ID: 27006338
[TBL] [Abstract][Full Text] [Related]
40. Masitinib for the treatment of mild to moderate Alzheimer's disease.
Folch J; Petrov D; Ettcheto M; Pedrós I; Abad S; Beas-Zarate C; Lazarowski A; Marin M; Olloquequi J; Auladell C; Camins A
Expert Rev Neurother; 2015 Jun; 15(6):587-96. PubMed ID: 25961655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
